Bloomage Biotech

Bloomage Biotech (688363) is a well-known biotechnology company and bioactive materials company, primarily focusing on functional sugars and amino acids that contribute to human health. It is committed to bringing new life experiences of health, beauty, and happiness to humanity. The company is an integrated hyaluronic acid industry chain platform that encompasses research and development, production, and sales, with its microbial fermentation technology for producing hyaluronic acid holding a leading position. Relying on two core technology platforms—microbial fermentation and cross-linking—the company has established a full industry chain business system for bioactive materials, ranging from raw materials to medical terminal products, functional skincare products, and functional foods. It serves manufacturing enterprises, medical institutions, and end users in the global pharmaceuticals, cosmetics, and food industries. Bloomage Biotech has always believed that the vitality of an enterprise stems from continuous innovation capabilities and sustained profitability. By establishing a core position in the industry chain, supply chain, and value chain, it ensures the realization of medium- and long-term strategic goals. Through its two core technology platforms of microbial fermentation and cross-linking, the company relies on its technological strength and product strength to become a standard-setter and leader in the industry; through its market strength and brand strength, it becomes a key link in controlling intermediate steps in the supply chain; and through its technological strength, product strength, and brand strength, it builds corporate competitiveness as a core hub for optimized resource allocation in the value chain. Science and innovation are the foundation of Bloomage Biotech’s healthy development and also the new driving force behind its rapid growth. Over the past 20 years, Bloomage Biotech has consistently relied on technological strength to build brand strength, actively enhancing its brand's scientific and technological innovation capabilities. On November 6, 2019, Bloomage Biotech successfully listed on the STAR Market, ushering in a new chapter of innovative development! In the future, Bloomage Biotech will continue to build corporate competitiveness centered on technological strength, product strength, and brand strength. Utilizing core biotechnologies, it will develop more high-quality bioactive substances and related end products to further enhance their efficacy in promoting human health and beauty. The company aims to create nationally trusted and proud Chinese products and become a respected and beloved national enterprise worldwide.